Filters (0 applied)
Total Profits:
$563.40
-$122 Loss
DCTHLong Stock
Entry comments: Playing some true pennies with DCTH. They are to be featured in a Video Training Session at conference on April 24 3pm Australian time. They have just begun Phase 3 trials for Patients with Hepatic Dominant Ocular Melanoma. It has yet to be approved by the FDA, however it has been in use since 2012 in Europe.
Exit comments: Reverse split killed it :/
$69 Profit
AXXALong Stock
$91 Profit
SBOTLong Stock
$56 Profit
AXXALong Stock
$58 Profit
HTBXLong Stock
$80 Profit
VLRXLong Stock
$50 Profit
HEARLong Stock
$154 Profit
CNETLong Stock
*Results may not be typical and may vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here.
Never attempt to copy or mirror the trades discussed on this website or in alerts. Attempting to do so may result in substantial financial losses. Alerts are not provided in real-time. For that reason, it is highly unlikely you will be able to buy the stocks at the same entry price, or sell the stocks at the same exit price, to achieve the same or similar profits obtained.
Never attempt to copy or mirror the trades discussed on this website or in alerts. Attempting to do so may result in substantial financial losses. Alerts are not provided in real-time. For that reason, it is highly unlikely you will be able to buy the stocks at the same entry price, or sell the stocks at the same exit price, to achieve the same or similar profits obtained.
